0001048477-24-000079.txt : 20240513
0001048477-24-000079.hdr.sgml : 20240513
20240513155727
ACCESSION NUMBER: 0001048477-24-000079
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240509
FILED AS OF DATE: 20240513
DATE AS OF CHANGE: 20240513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES
CENTRAL INDEX KEY: 0001221590
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 24938793
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
wk-form4_1715630235.xml
FORM 4
X0508
4
2024-05-09
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001221590
BIENAIME JEAN JACQUES
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO STREET
SAN RAFAEL
CA
94901
1
0
0
0
1
Common Stock
2024-05-09
4
M
0
20000
63.10
A
494994
D
Common Stock
2024-05-09
4
S
0
20000
81.62
D
474994
D
Common Stock
2024-05-10
4
M
0
20000
63.10
A
494994
D
Common Stock
2024-05-10
4
S
0
20000
81.14
D
474994
D
Common Stock
247333
I
Shares held by Jean-Jacques Bienaime Family Trust
Common Stock
100
I
Shares held as UTMA custodian for child 1
Common Stock
100
I
Shares held as UTMA custodian for child 2
Stock Option (Right to Buy Common Stock)
63.10
2024-05-09
4
M
0
20000
0
D
2014-12-04
2024-06-03
Common Stock
20000
71000
D
Stock Option (Right to Buy Common Stock)
63.10
2024-05-10
4
M
0
20000
0
D
2014-12-04
2024-06-03
Common Stock
20000
51000
D
Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.
Reflects the number of options outstanding after the transactions from this specific stock option grant.
/s/ Tae Sang Yoo, Attorney-in-Fact
2024-05-13